Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon-Reference-Cited by-同舟云学术

Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon

Published:2022-06 Issue:6 Volume:28 Page:
ISSN:1080-6040
Container-title:Emerging Infectious Diseases
language:
Short-container-title:Emerg. Infect. Dis.

Author:

Ndongo Francis Ateba,Guichet Emilande,Mimbé Eric Donald,Ndié Justin,Pelloquin Raphael,Varloteaux Marie,Esemu Livo,Mpoudi-Etame Mireille,Lamare Nadine,Edoul Ginette,Wouambo Rodrigue Kamga,Djomsi Dowbiss Meta,Tongo Marcel,Tabala Félicité Naah,Dongmo Rogacien Kana,Diallo Mamadou Saliou Kalifa,Bouillin Julie,Thaurignac Guillaume,Ayouba Ahidjo,Peeters Martine,Delaporte Eric,Bissek Anne-Cécile Zoung-Kanyi,Mpoudi-Ngolé Eitel

Publisher

Centers for Disease Control and Prevention (CDC)

Subject

Infectious Diseases,Microbiology (medical),Epidemiology

Reference13 articles.

1. World Health Organization. Coronavirus (COVID-19) dashboard [cited 2021 Nov 26]. https://covid19.who.int

2. Africa Centres for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19) [cited 2021 Nov 26]. https://africacdc.org/covid-19

3. Seroprevalence of anti-SARS-CoV-2 antibodies in Africa: A systematic review and meta-analysis.;Chisale;Rev Med Virol,2022

4. Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study.;Sagara;Clin Infect Dis,2022

5. Community SARS-CoV-2 seroprevalence before and after the second wave of SARS-CoV-2 infection in Harare, Zimbabwe.;Fryatt;EClinicalMedicine,2021

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seroprevalence of SARS‐CoV‐2 in 10 Regional Capitals of Cameroon, October–December 2020;Influenza and Other Respiratory Viruses;2024-03-27

2. High seroprevalence of severe acute respiratory syndrome coronavirus 2 among healthcare workers in Yaoundé, Cameroon after the first wave of Covid‐19 pandemic and associated factors;Influenza and Other Respiratory Viruses;2024-02

3. Seroprevalence of SARS‐CoV‐2 antibodies and associated risk factors during the second wave of infection in a university community in Cameroon;Influenza and Other Respiratory Viruses;2023-11

4. Nationwide retrospective mortality and seroprevalence of SARS-CoV-2 antibodies in Cameroon;Scientific African;2023-11

5. Unveiling the Dynamics of the Omicron Variant: Prevalence, Risk Factors, and Vaccination Efficacy during the Third Wave of Covid-19 in Indonesia's Gowa Regency;International Journal of Statistics in Medical Research;2023-09-18